PIRATE: pediatric imaging response assessment and targeting environment

By combining the strengths of various imaging modalities, the multimodality imaging approach has potential to improve tumor staging, delineation of tumor boundaries, chemo-radiotherapy regime design, and treatment response assessment in cancer management. To address the urgent needs for efficient tools to analyze large-scale clinical trial data, we have developed an integrated multimodality, functional and anatomical imaging analysis software package for target definition and therapy response assessment in pediatric radiotherapy (RT) patients. Our software provides quantitative tools for automated image segmentation, region-of-interest (ROI) histogram analysis, spatial volume-of-interest (VOI) analysis, and voxel-wise correlation across modalities. To demonstrate the clinical applicability of this software, histogram analyses were performed on baseline and follow-up 18F-fluorodeoxyglucose (18F-FDG) PET images of nine patients with rhabdomyosarcoma enrolled in an institutional clinical trial at St. Jude Children's Research Hospital. In addition, we combined 18F-FDG PET, dynamic-contrast-enhanced (DCE) MR, and anatomical MR data to visualize the heterogeneity in tumor pathophysiology with the ultimate goal of adaptive targeting of regions with high tumor burden. Our software is able to simultaneously analyze multimodality images across multiple time points, which could greatly speed up the analysis of large-scale clinical trial data and validation of potential imaging biomarkers.

[1]  Gordon C Jayson,et al.  Molecular imaging of antiangiogenic agents. , 2005, The oncologist.

[2]  Talma Hendler,et al.  Delineating gray and white matter involvement in brain lesions: three-dimensional alignment of functional magnetic resonance and diffusion-tensor imaging. , 2003, Journal of neurosurgery.

[3]  Aswin L Hoffmann,et al.  Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[4]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[5]  T. Nakano,et al.  Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer. , 1996, International journal of radiation oncology, biology, physics.

[6]  F. d'Amore,et al.  Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. , 2006, Haematologica.

[7]  Elisabeth Kjellén,et al.  FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma , 2002, Head & neck.

[8]  Gábor Székely,et al.  Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  G. Johnson,et al.  Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. , 2003, AJNR. American journal of neuroradiology.

[10]  P. Wust,et al.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? , 2005, European Radiology.

[11]  M. Kraut,et al.  Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo , 2002, Annals of neurology.

[12]  Wilburn E Reddick,et al.  DCE‐MRI pixel‐by‐pixel quantitative curve pattern analysis and its application to osteosarcoma , 2009, Journal of magnetic resonance imaging : JMRI.

[13]  Di Yan,et al.  Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.

[14]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[15]  James M Provenzale,et al.  Imaging of angiogenesis: clinical techniques and novel imaging methods. , 2007, AJR. American journal of roentgenology.

[16]  J. Eary,et al.  Staging of head and neck squamous cell cancer with extended-field FDG-PET. , 2003, Archives of otolaryngology--head & neck surgery.

[17]  Open-source software for radiologists: a primer. , 2007, Clinical radiology.

[18]  G Johnson,et al.  Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. , 2007, AJNR. American journal of neuroradiology.

[19]  J. Yahalom,et al.  Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT) , 2005, European journal of haematology. Supplementum.

[20]  T. Irie,et al.  Intracellular reactions affecting 2-amino-4-([(11)C]methylthio)butyric acid ([(11)C]methionine) response to carbon ion radiotherapy in C10 glioma cells. , 2009, Nuclear medicine and biology.

[21]  E Bellon,et al.  Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  K. Brindle,et al.  Assessing responses to cancer therapy using molecular imaging. , 2006, Biochimica et biophysica acta.

[23]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[24]  A. Padhani,et al.  The RECIST criteria: implications for diagnostic radiologists , 2001 .

[25]  R. Hicks,et al.  Overview of early response assessment in lymphoma with FDG-PET , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[26]  Marco Brambilla,et al.  FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. , 2008, International journal of radiation oncology, biology, physics.

[27]  John L. Humm,et al.  Use of PET to monitor the response of lung cancer to radiation treatment , 2000, European Journal of Nuclear Medicine.

[28]  M. Sculpher,et al.  Assessment of the technology for functional imaging in cancer. , 2002, European journal of cancer.

[29]  R. Hicks,et al.  Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography. , 2008, International journal of radiation oncology, biology, physics.

[30]  A. Bjørnerud,et al.  Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes , 2008, American Journal of Neuroradiology.

[31]  N. Hylton.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Slobodan Devic,et al.  Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. , 2008, International journal of radiation oncology, biology, physics.

[33]  Cesare Guida,et al.  18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Response to radiation. , 2004, Seminars in radiation oncology.

[35]  Sanjiv S. Gambhir,et al.  AMIDE: A Free Software Tool for Multimodality Medical Image Analysis , 2003 .

[36]  Sadek Nehmeh,et al.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.

[37]  C. Jaffe.  Measures of response: RECIST, WHO, and new alternatives. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  B. Shulkin.  PET imaging in pediatric oncology , 2004, Pediatric Radiology.

[39]  Glyn Johnson,et al.  Comparison of region‐of‐interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas , 2007, Journal of magnetic resonance imaging : JMRI.

[40]  J W Langston,et al.  Diffusion tensor imaging of tract involvement in children with pontine tumors. , 2006, AJNR. American journal of neuroradiology.

[41]  M. Schwaiger,et al.  Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. , 2008, International journal of radiation oncology, biology, physics.

[42]  M. Schwaiger,et al.  Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[43]  L. Specht.  2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. , 2007, Seminars in radiation oncology.

[44]  Paul Kinahan,et al.  Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. , 2006, Medical physics.

[45]  Matthew S. Brown,et al.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. , 2009, Radiology.

[46]  Yoshimi Anzai,et al.  FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation , 2005, Head & neck.

[47]  Edward J Escott,et al.  Free DICOM image viewing and processing software for your desktop computer: what's available and what it can do for you. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[48]  Naoki Kagawa,et al.  11C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison , 2010, NeuroImage.

[49]  B. Shulkin,et al.  Technical issues in performing PET studies in pediatric patients. , 2004, Journal of nuclear medicine technology.

[50]  W. Reddick,et al.  Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma , 2001, Cancer.

[51]  R. Cerfolio,et al.  Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. , 2004, The Annals of thoracic surgery.

[52]  Wilson Roa,et al.  A local contrast based approach to threshold segmentation for PET target volume delineation. , 2006, Medical physics.

[53]  Anne Bol,et al.  A gradient-based method for segmenting FDG-PET images: methodology and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  R. Alonzi,et al.  Functional imaging in clinical oncology: magnetic resonance imaging- and computerised tomography-based techniques. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[55]  J O Barentsz,et al.  Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. , 2009, Cancer treatment reviews.

[56]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[57]  Karl Herholz,et al.  Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography , 2004, Clinical Cancer Research.

[58]  L. Specht,et al.  Clinical impact of FDG‐PET/CT in the planning of radiotherapy for early‐stage Hodgkin lymphoma , 2007, European journal of haematology.

[59]  P. Vaupel,et al.  Hypoxia and Radiation Response in Human Tumors. , 1996, Seminars in radiation oncology.